Medicare Advantage
Advanced Search
  
MPNewsFlashTopicPub
  
  
MPPurposePub
  
  
7/29/2022
Coverage of the COVID-19 Vaccination for Medicare Advantage Members (Retroactively effective to June 17, 2022, Issued July 29, 2022)
0.1
This communication provides notice regarding information and procedure codes related to the coverage of SARS-CoV-2 (Coronavirus Disease 2019 (COVID-19)) vaccines and administration of the vaccines​ that have been granted FDA approval and/or have received an Emergency Use Authorization. Coverage of SARS-CoV-2 (Coronavirus Disease 2019 (COVID-19)) vaccines granted an EUA shall remain in effect during the applicable EUA declaration, unless the specific EUA for a SARS-CoV-2 (Coronavirus Disease 2019 (COVID-19)) vaccine has been terminated and/or revoked. 

Coverage of the COVID-19 Vaccination for Medicare Advantage Members (Retroactively effective to June 17, 2022, Issued July 29, 2022)593094fc-88a8-4f46-aa47-014077911c19
6/29/2022
07/01/2022 CPT & HCPCS Quarterly Code Update Coverage Determinations for Medicare Advantage Products
0
The intent of this document is to communicate Medicare Advantage Product coverage determinations for services identified through the Quarterly Code Update process. The procedure codes that represent these services will become effective on 07/01/2022, unless otherwise noted.

For more information related to these services, please refer to specific policies when applicable.​​​​​​
07/01/2022 CPT & HCPCS Quarterly Code Update Coverage Determinations for Medicare Advantage Productsb10535ed-63aa-4e28-8c6a-7e87855dd56d
4/27/2022
Testing for SARS-CoV-2 (Coronavirus Disease 2019 (COVID-19)) for Independence Medicare Advantage Members (Updated April 27, 2022)
0.1
The purpose of this communication is to provide advance notice regarding information and procedure codes related to testing for SARS-CoV-2 (Coronavirus Disease 2019 (COVID-19)) for Independence Medicare Advantage members.

Testing for SARS-CoV-2 (Coronavirus Disease 2019 (COVID-19)) for Independence Medicare Advantage Members (Updated April 27, 2022)b23ef10a-9791-4b33-b81a-61bcbf17cfaa
4/25/2022
Preventive Coverage of 15-Valent Pneumococcal Conjugate Vaccine and 20-Valent Pneumococcal Conjugate Vaccine for Medicare Advantage Members
0.1
The purpose of this communication is to provide notice regarding the expanded preventive coverage criteria for 15-Valent Pneumococcal Conjugate Vaccine and 20-Valent Pneumococcal Conjugate Vaccine​​​ for Medicare Advantage members effective July 1, 2021​.
Preventive Coverage of 15-Valent Pneumococcal Conjugate Vaccine and 20-Valent Pneumococcal Conjugate Vaccine for Medicare Advantage Members434e6fa8-8072-42a2-bd17-e1f8f39db5c1
4/12/2022
04/01/2022 CPT & HCPCS Quarterly Code Update Coverage Determinations for Medicare Advantage Products (Updated April 12, 2022)
0.1
The intent of this document is to communicate Medicare Advantage Product coverage determinations for services identified through the Quarterly Code Update process. The procedure codes that represent these services will become effective on 04/01/2022, unless otherwise noted.

For more information related to these services, please refer to specific policies when applicable.​​​​​
04/01/2022 CPT & HCPCS Quarterly Code Update Coverage Determinations for Medicare Advantage Products (Updated April 12, 2022)b2128b73-f094-40fc-bc15-6c2e4f19ac80
3/21/2022
Expanded Preventive Coverage for Lung Cancer Screening with Low Dose Computed Tomography
0.1
The purpose of this communication is to provide notice regarding the expanded preventive coverage criteria for lung cancer screening with low dose computed tomography for Independence Medicare Advantage members effective February 10, 2022.​​​
Expanded Preventive Coverage for Lung Cancer Screening with Low Dose Computed Tomography548f88be-de3e-45a9-98e2-771913b847ed
12/31/2021
Telehealth Services for Medicare Advantage Members
0.1

The purpose of this document is to provide advance notice regarding coverage for telehealth services for our Medicare Advantage members in response to Coronavirus Disease 2019 (COVID-19).

Telehealth Services for Medicare Advantage Membersf4aa34e8-11ba-4eee-81de-bf2f7e35e721
12/31/2021
01/01/2022 CPT & HCPCS Quarterly Code Update Coverage Determinations for Medicare Advantage Products (Updated January 7, 2022)
0.1
The intent of this document is to communicate Medicare Advantage Product coverage determinations for services identified through the Quarterly Code Update process. The procedure codes that represent these services will become effective on 01/01/2022, unless otherwise noted.
01/01/2022 CPT & HCPCS Quarterly Code Update Coverage Determinations for Medicare Advantage Products (Updated January 7, 2022)caa20a02-9c8b-4daf-981c-1acac3da57b1
12/7/2021
Changes for COVID-19 Vaccination and Pharmaceutical Treatments for Medicare Advantage Members to Become Effective January 1, 2022
0.1
The purpose of this communication is to provide advance notification of changes for COVID-19 vaccination and pharmaceutical treatment of COVID-19 scheduled to become effective on January 1, 2022 for Medicare Advantage members. ​
Changes for COVID-19 Vaccination and Pharmaceutical Treatments for Medicare Advantage Members to Become Effective January 1, 2022645e03c4-2c9d-4325-99f0-afa969c0f8cb
10/1/2021
10/1/2021 CPT & HCPCS Quarterly Code Update Coverage Determinations for Medicare Advantage Products
0.1
The intent of this article is to communicate Medicare Advantage Product coverage determinations for services identified through the Quarterly Code Update process. The procedure codes that represent these services will become effective on 10/1/2021, unless otherwise noted.

For more information related to these services, please refer to specific policies when applicable.​​​​​​

10/1/2021 CPT & HCPCS Quarterly Code Update Coverage Determinations for Medicare Advantage Productsda4807d7-c8e8-4da3-adb7-5a156ce37fc4
6/4/2021
Notification of Upcoming Changes to Temporary COVID-19 Waivers of Certain Requirements Related to Respiratory Equipment and Related Supplies
0.1
The purpose of this communication is to provide advance notice regarding the reinstatement of certain pre-PHE requirements/limits related to respiratory equipment/related supplies.
Notification of Upcoming Changes to Temporary COVID-19 Waivers of Certain Requirements Related to Respiratory Equipment and Related Suppliesf0cd547c-047a-4d87-9d85-8a03d1d77946
4/1/2021
4/1/2021 CPT & HCPCS Quarterly Code Update Coverage Determinations for Medicare Advantage Products
0.1
The intent of this article is to communicate Medicare Advantage Product coverage determinations for services identified through the Quarterly Code Update process. The procedure codes that represent these services will become effective on 4/1/2021, unless otherwise noted.
4/1/2021 CPT & HCPCS Quarterly Code Update Coverage Determinations for Medicare Advantage Productsd2c73a29-4d27-43bb-be4a-15bcdcf54a84
1/4/2021
1/1/2021 CPT & HCPCS Annual Code Update Coverage Determinations for Medicare Advantage Products
0
The intent of this document is to communicate Medicare Advantage Product coverage determinations for services identified through the Annual Code Update process. 


1/1/2021 CPT & HCPCS Annual Code Update Coverage Determinations for Medicare Advantage Products83b993ed-7be0-47bc-983e-86d958abfdc6
10/22/2020
Pharmaceutical Prophylaxis and Treatments of COVID-19 for Independence Medicare Advantage Members (Updated July 5, 2022).
0.1

The purpose of this document is to communicate the Company's coverage position for Pharmaceutical Prophylaxis and Treatment of COVID-19 for Independence Medicare Advantage members. 

Pharmaceutical Prophylaxis and Treatments of COVID-19 for Independence Medicare Advantage Members (Updated July 5, 2022).245fdad3-147e-43fb-a137-c64424452ecb
6/30/2020
Waiver of certain requirements during COVID-19 outbreak related to Durable Medical Equipment (DME), prosthetics, orthotics, and supplies for Medicare Advantage members (Updated December 15, 2021)
5


The purpose of this NewsFLASH is to provide advance notice regarding the temporary waiver of certain requirements for Durable Medical Equipment (DME), as well as prosthetics, orthotics, and supplies in response to Coronavirus Disease 2019 (COVID-19).

This communication addressing DME, prosthetics, orthotics, and supplies shall remain in effect through the end of the Public Health Emergency.

Waiver of certain requirements during COVID-19 outbreak related to Durable Medical Equipment (DME), prosthetics, orthotics, and supplies for Medicare Advantage members (Updated December 15, 2021)df1f110b-c86e-4b87-9159-ef26b65cd328
4/29/2020
Direct Supervision Requirements for Incident to Services Performed by Certified Registered Nurse Practitioners (CRNPs) and Physician Assistants (PAs) in Response to COVID-19 (Updated December 15, 2021)
1
The purpose of this News Article is to provide advance notice regarding direct supervision requirements for Incident to services performed by Certified Registered Nurse Practitioners (CRNPs) and Physician Assistants (PAs) in response to Coronavirus Disease 2019 (COVID-19).
Direct Supervision Requirements for Incident to Services Performed by Certified Registered Nurse Practitioners (CRNPs) and Physician Assistants (PAs) in Response to COVID-194FDDC2AFA5B549C885258558007D7B93
4/14/2020
Ground Ambulance Transport Services (Emergency and Nonemergency) for Medicare Advantage Members (Updated December 15, 2021)
0


The purpose of this communication is to provide advance notice regarding the temporary expansion of the list of allowable destinations for ground ambulance transports AND to convey coverage criteria for medically necessary ground ambulance services without a transport in response to the Public Health Emergency (PHE) for the COVID-19 pandemic. 

Ground Ambulance Transport Services (Emergency and Nonemergency) for Medicare Advantage Members (Updated December 15, 2021)f43a2ed7-486a-48bf-bb49-fa849eb03cfb
4/14/2020
Medicare Diabetes Prevention Program in Response to COVID-19 Outbreak (Updated December 15, 2021)
0.1
The purpose of this NewsFLASH is to provide advance notice regarding coverage for Medicare diabetes prevention program in response to Coronavirus Disease 2019 (COVID-19).
Medicare Diabetes Prevention Program in Response to COVID-19 Outbreak (Updated December 15, 2021)4d8e7d77-5a72-4739-96cc-d1c17590ac58
9/9/2015
​Clarification Regarding Coverage for the VisibiliT™ Test
1
The purpose of this article is to communicate that the VisibiliT™ test (represented by procedure code 0009M) is medically necessary with criteria since this code's effective date of 07/01/2015. This communication supersedes any previous communications for 0009M from the Company.
Clarification Regarding Coverage for the VisibiliT™ Test3868AC77FDADAF3B85257EBB005F4A43